Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 2/20 | 0.31 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | SCN1A | P35498 | 1/20 | 0.30 |
| ▸ | SCN4A | P35499 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.30 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6920162 | 0.78 | LMNA (0.32) | LMNAMMP9CACNA1FALDH1A1MAPT | |
| SCHEMBL1132696 | 0.76 | LMNA (0.32) | LMNAMMP9CACNA1FALDH1A1MAPT | |
| Butadiene SCHEMBL1304779 | 0.71 | GAA (0.32) | GAAHPGDMAPK1LMNAMMP9 | |
| SCHEMBL11107818 | 0.70 | GAA (0.37) | GAAHPGDMAPK1CACNA1FALDH1A1 | |
| SCHEMBL7966076 | 0.70 | GAA (0.30) | GAAHPGDMAPK1 | |
| Formaldehyde SCHEMBL1396256 | 0.67 | LMNA (0.35) | LMNAMMP9CACNA1FALDH1A1MAPT | |
| SCHEMBL11085221 | 0.67 | — | — | |
| SCHEMBL22069 | 0.66 | — | — | |
| SCHEMBL4558728 | 0.66 | LMNA (0.38) | LMNAMMP9CACNA1FALDH1A1MAPT | |
| SCHEMBL20189247 | 0.64 | SMN1; SMN2 (0.44) | GAAHPGDMAPK1MMP9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294185-B1 | STABLE, INSOLUBLE BIOCIDES WHICH RELEASE ONLY SMALL AMOUNTS OF FREE HALOGEN,DISINFECTANTS | AUBURN UNIVERSITY | 2001-09-25 | — | — | US | claimed |
| WO-1996008949-A2 | NOVEL MONOMERIC AND POLYMERIC CYCLIC AMINE AND N-HALAMINE COMPOUNDS | AUBURN UNIVERSITY (US) | 1996-03-28 | — | — | WO | claimed |
| US-20170240435-A1 | POLYMERIC HYBRID PARTICLE CONTAINING NANO PARTICLES AND USES | HALOSOURCE, INC. (US) | 2017-08-24 | — | — | US | disclosed |
| EP-3206496-A1 | POLYMERIC HYBRID PARTICLE CONTAINING NANO PARTICLES AND USES | Halosource, Inc. (US) | 2017-08-23 | — | — | EP | disclosed |
| WO-2016061265-A1 | POLYMERIC HYBRID PARTICLE CONTAINING NANO PARTICLES AND USES | HALOSOURCE, INC. (US) | 2016-04-21 | — | — | WO | disclosed |
| US-6294185-B1 | STABLE, INSOLUBLE BIOCIDES WHICH RELEASE ONLY SMALL AMOUNTS OF FREE HALOGEN,DISINFECTANTS | AUBURN UNIVERSITY | 2001-09-25 | — | — | US | disclosed |
| US-6020491-A | Monomeric and polymeric cyclic amine and N-halamine compounds | AUBURN UNIVERSITY (US) | 2000-02-01 | — | — | US | disclosed |
| US-5889130-A | DEPOLYMERIZING OF POLY-4-VINYLACETOPHENONE FORMING 4-VINYLPHENYL(HYDANTOIN OR TRIAZINE); POLYMERIZING | AUBURN UNIVERSITY (US) | 1999-03-30 | — | — | US | disclosed |
| US-5808089-A | BIOCIDES | AUBURN UNIVERSITY (US) | 1998-09-15 | — | — | US | disclosed |
| US-5670646-A | HEATING POLYVINYLACETOPHENONE UNDER VACUUM TO CRACK IT TO CORRESPONDING MONOMER, CONVERTING ACETO MOIETY TO HYDANTOIN OR TRIAZINE-2,4-DIONE | AUBURN UNIVERSITY (US) | 1997-09-23 | — | — | US | disclosed |
| WO-1996008949-A2 | NOVEL MONOMERIC AND POLYMERIC CYCLIC AMINE AND N-HALAMINE COMPOUNDS | AUBURN UNIVERSITY (US) | 1996-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240435-A1 | POLYMERIC HYBRID PARTICLE CONTAINING NANO PARTICLES AND USES | DNMT1, DNMT3A, PUF60 | GAA 3171/4885HPGD 3914/4885MAPK1 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.